Journal of Thrombosis and Thrombolysis
A Journal for Translation, Application and Therapeutics in Thrombosis and Vascular Science
Journal of Thrombosis and Thrombolysis is a long-awaited resource for contemporary cardiologists, hematologists, vascular medicine specialists and clinician-scientists actively involved in treatment decisions and clinical investigation of thrombotic disorders involving the cardiovascular and cerebrovascular systems. The principal focus of the Journal centers on the pathobiology of thrombosis and vascular disorders and the use of anticoagulants, platelet antagonists, cell-based therapies and interventions in scientific investigation, clinical-translational research and patient care.
The Journal will publish original work which emphasizes the interface between fundamental scientific principles and clinical investigation, stimulating an interdisciplinary and scholarly dialogue in thrombosis and vascular science. Published works will also define platforms for translational research, drug development, clinical trials and patient-directed applications. The Journal of Thrombosis and Thrombolysis' integrated format will expand the reader's knowledge base and provide important insights for both the investigation and direct clinical application of the most rapidly growing fields in medicine-thrombosis and vascular science.
The Journal seeks original manuscripts devoted to fundamental science in cardiovascular disease, laboratory investigation, pharmacogenetics, clinical research, global health and epidemiology. State-of-the-art reviews, position papers and editorials will be summoned by invitation from the editor or an appointed guest editor. The Journal will publish special issues and supplements from national and international symposia and scientific committees in a timely fashion by working closely with organizers and contributing authors.
Resource utilization and hospital readmission associated with gastrointestinal bleeding in patients with continuous-flow left ventricular assist devices
Efficacy and safety of more potent antiplatelet therapy with vorapaxar in patients with impaired renal function
To view the rest of this content please follow the download PDF link above.